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NOVEL MUSCLE CONTUSION INJURY MODEL AND REPAIR MECHANISM  
 
DANIELLE CORBIN 
 
ABSTRACT 
  This study investigates the skeletal muscle repair and regeneration process 
following blunt trauma injury in murine models. Skeletal muscle injury is recorded most 
often in sports injuries and include strains and sprains, contusions, and bruising, however, 
there is growing consensus about the role skeletal muscle plays in the reparative process 
of bone fractures. Skeletal muscle stem cells or satellite cells are mesenchymal stem cell 
derived cells that exist between the basal lamina and cell membrane of muscle fibers 
usually in close proximity to capillary beds. After a traumatic injury, satellite cells 
respond to the influx of signaling from immune cells, oxygen tension, and myogenic 
proteins which influence differentiation into myoblasts for repair of tissue damage. 
Research continues to elucidate the relationship between bone and skeletal muscle 
following trauma injuries. Skeletal muscle stem cells play a vital role in fracture healing, 
and in certain conditions, are even induced into the osteogenic pathway. The goals of this 
study are to characterize the temporal progression of myogenesis during muscle repair 
that will be used with future studies of muscle and bone injury. And to identify potential 
crosstalk mechanisms between muscle and bone repair during trauma.  
In our experiment model trauma was introduced to mice with a modified muscle 
contusion device where a weight was dropped onto the femoral quadriceps muscles and 
the quadriceps and biceps muscle tissues were harvested at post-operative days (POD) 2, 
4, 12, 16, and 24. Reverse-Transcriptase Quantitative Polymerase Chain Reaction was 
  vii 
used to analyze gene expression profiles for satellite/stem cells (Pax7 and Prx1), muscle 
regeneration (MyoD, Myf5, Myl2, and Myh1), angiogenesis (VegfA, VegfR2), myokine 
(Myostatin and IL6), and BMP signaling (ID1).  
Our findings indicate that both Pax7 and Prx1 expression slightly decreased after 
injury but showed a significant (p<0.05) increase and peak of expression at POD 16 in 
the femoral quadriceps muscles. The early myogenic genes, MyoD and Myf5 peaked early 
at POD 4 while the adult myofiber markers, Myl2 and Myh2, peaked later at POD 16 in 
the femoral quadriceps muscles. Only slight changes were observed in the femoral biceps 
muscles. The angiogenic genes peaked at POD16 in the femoral quadriceps muscles and 
POD 12 in the femoral biceps muscles. The expression of Myostatin, an inhibitor of 
muscle mass, decreased early (POD 4 and 12) however showed a non-significant increase 
at POD 16 in the femoral quadriceps muscles. Lastly, the expression of ID1, which is 
downstream target of BMP signaling peaked early at POD 4 in the femoral quadriceps 
muscles.   
These data indicates that stem/satellite cells decrease in response to muscle injury 
but by POD 4, myogenic commitment and programming occurs. While early myogensis 
occurs, BMP signaling peaks and Myostatin expression decreases suggesting a 
coordinated event.  Adult myofiber regeneration occurs in parallel to angiogenesis. The 
myogenic events were primarily isolated to the injured femoral quadriceps muscles. This 
model of muscle injury can be used to study muscle regeneration within context to bone 
injury.   
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INTRODUCTION 
 
 Skeletal muscle is the most abundant tissue in the human body constituting 
close to 40% of the total human body mass. Muscle injury and damage can stem from 
many origins and range from pathological conditions to acute trauma. Skeletal muscle 
injuries are the most common sports-related injuries (Boage et al., 2012) among 
athletes and include lacerations, strains, and contusions. Soft tissue trauma is also 
common among industrial workers and clinically manifest in localized pain, swelling, 
reduced range of motion and tenderness to palpation (Singh et al., 2017). Degenerative 
musculoskeletal disorders, which can be caused by ischemia or neurological 
pathologies, also provide pressing incentive to further comprehend the physiological 
mechanisms and factors surrounding muscle regeneration and repair. The purpose of 
this study is to investigate the mechanisms of muscle repair following blunt trauma in 
murine models. Isolating muscle injury and repair processes from complex 
musculoskeletal injuries will provide a context for understanding muscle injury repair 
mechanisms and crosstalk to bone during repair and regeneration.   
 
Development of Skeletal Muscle, Satellite Cells, and Pax 7 
Skeletal muscle and connective tissue of vertebrates develop from the 
mesoderm germ layer and neural crest during embryogenesis. A germ layer is primary 
layer of cells that form during the early stages of embryo growth. The mesoderm can 
be divided into the paraxial, intermediate, and lateral mesoderm from the midline 
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position. During the third week of embryogenesis the mesoderm undergoes 
somitogenesis, where paired cell swellings (somites) appear from the rostral to caudal 
end of the embryo, on the paraxial mesoderm (lateral to the neural groove). Somite 
regions differentiate into dermamyotome (dermal and muscle components) and 
sclerotome (vertebral column component). The central dermamyotome region contains 
Pax7 positive progenitor cells that will develop into skeletal muscle (Relaix et al., 
2005). Cells derived from this region continue to differentiate based on cell signaling 
and gene expression and eventually splits into a dermatome (contributes to the 
connective tissue of the neck, skin, and fat) and a myotome. Myotomes then 
differentiate into myoblasts which give rise to the myofibers that form skeletal muscle 
(Yin et al., 2013), and at this point they cannot reenter the cell cycle or regenerate 
themselves in any capacity. Myotome cells can also remain as a proliferating reserve 
cells in the muscle mass. These prenatal mesenchymal stem cells continue to migrate 
and differentiate throughout the embryo. In late-stage fetal development these reserve 
cells adopt their satellite cell positioning (Relaix et al., 2005). Satellite cells exist 
between the basal lamina and cell membrane of myofibers. Satellite cells are the 
myogenic progenitor cells of post-natal muscle, it is common belief that satellite cells 
self-repopulate through asymmetrical division, where one cell differentiates into a 
myoblast and the other continues to proliferate or become quiescent in response to 
damage (Zammit et al., 2006, Relaix et al., 2006).   
Pax 7 and is a protein member of the Pax gene family that acts as a 
transcription factor with a paired box/homeodomain binding domain. Pax 3 is a 
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paralogue of Pax 7 and also plays a key role in the specification of cells that enter the 
myogenic program. Pax 3 is critical for delamination and migration of muscle 
precursors from somites to the appendages (Olguin et al., 2007). In the Pax 3/Pax 7 
knockout, mice show major deficits in skeletal muscle development and cessation of 
myogenesis in late embryonic development (Relaix et al., 2005, Kansal et al., 2019). 
Pax 3 expression is down-regulated in satellite cells before birth.  In Pax 7 
homogenous knockouts, mice have no gross muscle defects though adult skeletal 
muscles have a receding number (Relaix et al., 2005) or completely devoid of satellite 
cells (Olguin et al., 2007). Pax 7 mutant mice also show reduced muscle growth, 
increased muscular atrophy, and extreme deficit in muscle regeneration after injury 
(Olguin et al., 2007).  In vitro, Pax 7 expression is lower in recently activated 
proliferating satellite cells and is rapidly down regulated in cells that are committed to 
terminal differentiation. The role of Pax 7 is therefore paramount to satellite cell 
specification, survival, and renewal and hereby vital to skeletal muscle repair and 
regeneration.  
Paired related homeobox 1 (Prx 1 or Prrx1) is a transcription factor expressed 
prenatally during limb bud formation and plays a significant role in craniofacial bone 
development. Postnatal cells derived from Prx1 cells are at the center of bone 
homeostasis and fracture repair (Wilk et al., 2017) because inactivation of key 
osteogenic factors such as RANKL (receptor activator of nuclear factor) κB ligand or 
BMP-2 (bone morphogenetic protein 2) expression in these cells causes osteopetrosis 
(“stone bone”) and low-bone-mass phenotypic bones respectively (Wilk et al., 2017). 
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Post-natal cells expressing Prx 1 have been shown in culture to differentiate into 
osteoblasts and chondroblasts and thus, their properties suggest that cells expressing 
Prx 1 can be used to mimic and characterize the behavior of skeletal muscle stem cells 
(Wilk et al., 2017).   
 
 
Muscle Injury Pathobiology  
According to the American Journal of Sports Medicine, skeletal muscle 
follows three consecutive steps from injury to repair and this repair process remains 
consistent regardless of the cause (strain, contusion, or laceration) of injury. It is 
however dependent on many other cell types including macrophages, satellite cells, 
fibrocyte/adipocyte precursors, interstitial connective tissue, and endothelial cells for 
angiogenesis (Hardy et al. 2016).  
 The first phase is destruction, which is characterized by the rupture and 
necrosis of skeletal muscle fibers, hematoma formation between muscle stumps, and 
inflammatory cell response (Figure 2) (Järvinen et al., 2005). 
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Figure 1: Skeletal Muscle Healing Schematic. This image illustrates how skeletal muscle repairs 
and regenerates itself after suffering an injury.  Day 2: The necrotized parts of the transected 
myofibers are being removed by macrophages while, concomitantly, the formation of the connective 
tissue scar by fibroblasts has begun in the central zone.  Day 3: Satellite cells have become activated 
within the basal lamina cylinders in the regeneration zone.  Day 5: myoblasts have fused into 
myotubes in the regeneration zone, and the connective tissue in the central zone has become denser.  
Day 7: The regenerating muscle cells extend out of the old basal lamina cylinders into the central zone 
and begin to pierce through the scar.  Day 14: the scar of the central zone has further condensed and 
reduced in size, and the regenerating myofibers close the central zone gap.  Day 21: the interlacing 
myofibers are virtually fused with little intervening connective tissue (scar) in between. Modified 
from Järvinen, Tero AJSM 2005 
 
 
Neutrophils begin invasion within an hour of injury and release proteases to aid 
with degrading cellular debris (Tidball, 2005). The concentration of neutrophils can 
remain elevated for up to 5 days. Within hours of injury the torn blood vessels allow 
polymorphonuclear leukocytes to relocate to the site of injury, and become monocytes 
that eventually become macrophages. The macrophages remove necrotic factors and 
work in tandem with fibroblasts to secrete growth factors, cytokines, and chemokines 
(Baoge et al., 2012). Satellite cells become active within 18 hours due to chemical 
stimulus and will participate in myofiber remodeling and repair process. The tissue 
damage also releases growth factors from the extracellular matrix (ECM) of 
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myofibers which initiates signal cascades. These factors include fibroblast growth 
factor (FGF) which stimulate and inhibit satellite cell differentiation, insulin-like 
growth factor-1 (IGF-1), insulin-like growth factor-2 (IGF-2) which solely stimulate 
differentiation, transforming growth factor-β (TGF-β) which stimulates collagen 
deposition, hepatocyte growth factor (HGF), tumor necrosis factor-α (TNF-α), and 
interleukin-6 (IL-6) which can activate the myogenic precursor, the satellite (stem) 
cell (Boage et al., 2012). Interleukin 6 (IL-6) is a cytokine released by metabolically 
active skeletal muscle. IL-6 has pleiotropic effects; stimulating B cells, hematopoietic 
stem cells, and hepatocytes due to its structural similarity to hepatocyte-stimulating 
factor (HSF) and hybridoma/plasmacytoma growth factor (HPGF) (Forcina et al., 
2018). Skeletal muscle produces increased IL-6 during exercise which acts locally and 
in the circulation increasing muscle glucose uptake, angiogenesis, lipolysis, and 
muscle hypertrophy. Excess IL-6 is correlated with muscle atrophy and muscle 
wasting. Interleukin 1 (IL-1) is a master pro-inflammatory cytokine that lowers the 
pain threshold in many tissues (Dinarello et al., 2012). There are two IL-1 genes in 
circulation, an alpha and beta, that both bind to the same IL-1 receptor which is 
present in nearly all cells. Due to its role in numerous pathological conditions 
(rheumatoid arthritis, traumatic knee injuries, osteomyelitis, etc.) most research studies 
focus on ways to dampen the effects of IL-1. IL-1 exists in membrane fragments 
known as apoptotic bodies which are active in inducing neutrophil infiltration through 
inflamed or damaged blood vessels (Dinarello et al., 2012). IL-1 also extends 
neutrophil survival and contributes to the unique behaviors of activated neutrophils.  
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Phase two is the repair phase and is categorized by phagocytosis of the 
necrotized tissue, regeneration of myofibers, production of a connective tissue scar, 
and capillary infiltration to the injured area (Järvinen et al., 2005). Activated satellite 
cells proliferate and differentiate into new myoblasts that fuse to the injured 
myofibers, filling the gap created by the injury/phagocytosis. Repair is also executed 
by the formation of connective tissue by fibrin and fibronectin from the hematoma that 
formed during phase one. The scar tissue is essential in giving the muscle strength to 
withstand contractions while providing an anchoring site for fibroblasts to infiltrate the 
granulated tissue (Baoge et al., 2012). Dense scar tissue results from the excessive 
proliferation of the fibroblasts which interferes with the repair and regeneration 
process. Dense connective tissue may lead to incomplete functional recovery of the 
injured muscle during the remodeling phase.  
The third phase is remodeling. It is characterized by the maturation of 
myoblasts into myofibers and the reorganization and strengthening of the scar tissue 
through contractions. During this phase, the muscle is expected to return to functional 
capacity (Järvinen et al., 2005). 
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Satellite Cells and Differentiation 
A muscle fiber is a multinucleated cell that develops from multiple myoblasts 
that fuse into a myotube. The myotubes continues to grow and produce proteins that 
will help aid in its ability to become contractile. Myosin light chain- 2 (Myl 2 or 
MLC-2) is a protein in the sarcomere of muscles that binds calcium and contributes to 
the contractile property of muscle (Sheikh et al., 2015). Myosin heavy chain (Myh 1 or 
MHC) is an ATP-dependent motor protein that also contributes to the contractile 
abilities of the sarcomere and thus skeletal muscle.  
Cells that initially enter the myogenic lineage depend on signaling created by 
the expression of myogenic determination factor (MyoD) gene family. The Myf 5 
gene is also a member of the myogenic determination gene family which regulates cell 
cycle withdrawal and induction of differentiation of skeletal muscle fibers (Kitzmann 
et al., 1998). Satellite cells give rise to a population of myogenic precursor cells that 
express Pax 7 in addition to MyoD and Myf 5. Myogenic precursor cells later exit the 
cell cycle and enter terminal differentiation and fuse to form new myofibers (Latroche 
et al., 2017).  
The somatic cell cycle consists of five stages: Growth 1 (G1), Synthesis (S), 
Growth 2 (G2), Mitosis (M), and Growth 0 (G0) or “naught”. All nucleated cells 
progress through the cell cycle during embryological development and differentiation. 
Genomic expression dictates when specific cell types “enter” (G1 through M) and 
“leave” (G0) the cell cycle.  
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In the process of repairing damaged skeletal muscle, satellite cells produce 
proliferating myoblasts that have unique gene expressions in relation to MyoD and 
Myf 5. Myo D peaks at mid-G1, has a minimum during G1/S, increases again during S 
to M and is absent during G0. (Kitzmann et al., 1998) Conversely, Myf 5 protein is 
high in the G0 stage and decreases during G1 before increasing again towards the end 
of G1, remaining consistent until mitosis (reminder: skeletal muscle cells are 
multinucleated cells that undergo the mitotic division of the nucleus without 
cytokinesis -the division of the cytoplasm-). 
Bone Morphogenetic Protein (BMP) is a member of the TGFβ signaling 
pathway and contributes to post-natal development of skeletal muscle, and satellite 
cells. The BMP family also plays a leading role in inducing osteoblast differentiation 
in multiple cell types. BMPs are growth factors involved in tissue structure throughout 
the body. Congenital BMP2 provides signaling to mesenchymal cells for proper 
differentiation into muscle, fat, cartilage, and bone (Rogers et al., 2015). BMP2 
signaling has a ubiquitous role in the development of mesenchymal derived tissues. 
The role that BMP2 signaling plays in adult muscle tissue is still under investigation. 
 
Skeletal Muscle Angiogenesis     
Angiogenesis is the process of forming capillaries from existing blood vessels, 
and it plays a vital role in normal bodily function and all three phases of muscle repair 
and regeneration. Skeletal muscle is highly vascularized with microvascular units 
comprising of 5-10 capillaries between 3-4 adjacent myofibers (Latroche et al., 2017). 
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Angiogenesis regulation follows a controlled circuit; if the metabolic needs of the 
muscle tissue are not being met by the microcirculatory environment, the mechanical 
stress on the capillary lumen exerts an upstream effect on the capillaries to proliferate. 
Muscle fibers and endothelial cells respond to hyperemia, elevated tissue strain, or 
excessive contraction/relaxation by translating gene expression profiles which alter the 
endothelial cell phenotype which lead to capillary growth (Olfert et al., 2016). 
Capillary growth involves a legion of signaling molecules including vasodilators 
nitrous oxide (NO), prostaglandins, and adenosine. NO is credited with stimulating 
vascular endothelial growth factor (VEGF) expression under skeletal muscle stress 
(Olfert et al., 2016). VEGF-A is a proangiogenic mitogen factor in skeletal muscle that 
promotes post-natal capillary formation in exercised, overloaded, and stretched 
muscles. VEGF-A increases vascular permeability and VEGF-A deficient mice lose 
their angiogenic ability in skeletal muscle (Olfert et al., 2016, Uchida et al., 2015). 
Cadherin 5 (Cdh5 or vascular endothelial cadherin (VE-cadherin)) is a vascular 
endothelial protein in cell-cell junctions that exists in a complex with two other 
proteins, vascular endothelial growth factor receptors (VEGFR-2) and platelet 
endothelial cell adhesion molecule (PECAM-1). Together, this complex transduces 
signals related to flow-dependent vasodilation, blood vessel remodeling, and 
atherosclerosis (Conway et al., 2017). VE-cadherin’s role in flow sensation involves 
PECAM-1’s activation of kinases that phosphorylate a key tyrosine in the junctional 
complex. The tyrosine can now interact with a polarity protein that can activate 
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inflammatory signaling in areas with turbulent flow and enhance flow dependent 
vascular remodeling (Conway et al., 2017).  
 After a traumatic event, satellite cells accumulate and proliferate near 
capillaries where they are stimulated by various growth factors secreted by endothelial 
cells (Singh et al., 2017). The proliferating satellite cells stimulate endothelial cells to 
form nascent capillaries and microvascular fragments (Singh et al., 2017). The number 
of capillaries surrounding a myofiber positively correlate with the number of satellite 
cells associated with the same myofiber (Latroche et al., 2017), and after injury, 
endothelial cells stimulate myogenic precursor cell growth and myogenic precursor 
cells exhibit angiogenic properties (Latroche et al., 2017).  
 
Use of Growth Factors for Muscle Regeneration  
It is possible to aid muscle regeneration with different biological growth 
factors. Injecting recombinant bFGF-6 (basic fibroblast growth factor) to the site of 
injury at the soleus muscle of adult mice can accelerate the differentiation of 
myotubes. (Armand et al., 2003). IGF-1 can also increase the efficiency of 
regenerating myofibers at two weeks post injury, and increase myofiber size at four 
weeks post injury (Takahashi et al., 2003), and even prevent age related muscle mass 
loss. However, IGF-1 may also lead to an increase in fibrosis due to the collagen 
stimulating and collagenase prohibiting properties of IGF-1. When IGF is injected in 
healthy old men loss of muscle mass typical with aging was prevented, however, due 
to the collagen simulating and collagenase prohibiting properties of IGF, there was an 
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increase in the development of fibrosis (Huard et al., 2002). bFGF-6 and IGF-1 both 
improve muscle performance, and even increase the number of regenerating myofibers 
by a factor of 3.5 (Kasemkijwattana et al., 1998). When HGF (50 ng) was injected into 
muscles on the day of injury, cells analyzed a day later showed a three-fold increase in 
MyoD positive cells compared to control muscle cells. HGF was also shown to 
increase the number of myogenic precursor cells, though that showed no improvement 
of the regeneration process (Miller et al., 2000). Combined we see how HGF effects 
the stem cell activation and differentiation.  
Biologics and growth factors can be used to modulate remodeling with 
minimal scaring being the most successful outcome during the remodeling phase. The 
fibrotic tissue is regulated by TGF-β1 in both animals and humans (Chan et al., 2005) 
and has become a target for inhibition. Two drugs that have successfully inhibited of 
TGF-β1 are suramin and decorin (Chan et al., 2005; Nozaki et al., 2008). Suramin is 
an antiparasitic and antitumor drug that binds competitively to the TGF-β1 receptor. 
There are minor effects when injected less than 7 days post injury but injury fibrosis 
decreased with high dose injection 14 days after injury. Suramin treated groups also 
showed a dose-dependent increase in regenerating myofibers. Once healed, suramin 
injected muscles were stronger than control muscles (not dose-dependent) and showed 
less fibrosis and overall better healing. Decorin is a protein member of the small 
leucine-rich proteoglycan (SLRP) gene family and has a broad binding repertoire that 
encompasses matrix structural components including collagens, growth factors in the 
TGF-β family (Neill et al., 2012). Injection of decorin 10 to 15 days post injury 
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significantly deceased total fibrosis and enhanced the regeneration of injured muscle 
in a dose-responsive fashion with no observed side effects (Fukushima et al., 2001). 
 
Soft Tissue Damage and Ectopic Bone Formation  
In the adult, damaged muscle cells are repaired or replaced by a derivative of 
multipotent mesenchymal stem cells (MSC’s) (Davis et al., 2015). Osteoblasts (secrete 
bone matrix), adipocytes, and chondrocytes are some of the cell lineages that originate 
from mesenchymal stem cells (Dunn et al.). Soft tissue injury healing plays a leading 
and vital role during the bone regeneration process (Davis et al., 2015). It has become 
more apparent that skeletal muscle is capable of providing osteoprogenitor cells to 
damaged periosteal tissue, and that muscular osteoprogenitor cells have similar 
potential to cells that are derived from the periosteum (Davis et al., 2015). In clinical 
cases of severe soft tissue injury, bone fracture healing is impeded compared to 
fractures with intact soft tissue. This poses a challenge for surgeons when facing 
crushed tissue or high energy trauma injuries which is quantified by the Gustilo-
Anderson open fracture classification scale. This scale heavily focuses on skeletal 
muscle and vascular damage with higher grade injures associated with higher risk of 
complications (Hacking). The relationship between successful skeletal muscle repair 
and regeneration and bone regeneration and remodeling has proven to be unavoidable.  
 Fracture repair consists of three consecutive phases: a reactive phase, a 
reparative phase, and a remodeling phase. The reactive phase lasts less than a week, 
and is characterized by the initial fracture, hematoma formed from torn vasculature, 
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the infiltration of immune cells (lymphocytes, polymorphonuclear cells, and 
monocytes), and the recruitment of fibroblasts to form granulation tissue (Marsell and 
Einhorn., 2011). Granulation tissue also plays a role in secreting cytokines that initiate 
osteogenic differentiation of MSC’s and promote angiogenesis (Einhorn and 
Gerstenfeld., 2015). The reparative phase of healing begins days after the reactive 
phase and lasts a few weeks. In this stage pluripotent MSC’s respond to local oxygen 
levels and strain and differentiate into fibroblasts, chondroblasts, or osteoblasts (Davis 
et al., 2015). Bone healing occurs through a direct intramembranous ossification 
method or an indirect combination of intramembranous and endochondral ossification 
methods. Intramembranous ossification involves lamellar bone regeneration and 
fixation for stabilization, while endochondral ossification begins with a fibrocartilage 
epicenter that is subsequently replaced by a bony callus and woven bone deposition 
(Marsell and Einhorn., 2011, Gerstenfeld et al., 2006). In the years following the 
fracture the bone enters the remodeling phase, where woven bone is replaced by 
lamellar bone which is gradually remodeled due to mechanical stress.  
 Skeletal muscle is now known to have roles in aiding fracture repair through 
assisting in callus formation. During the reparative phase of bone regeneration, the 
interface between muscle and bone has the densest formed callus suggesting that 
muscle is a contributor to ectopic bone formation (Davis et al., 2015). BMP’s are a 
family of growth factors involved in osteoblast differentiation and in the presence of 
BMP-2 cells derived from muscle are capable of expressing bone markers and forming 
bone (Gao et al., 2014). Muscle derived stem cells driven to osteogenic differentiation 
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can also give rise to chondrocytes and their potential for differentiation may rival their 
bone marrow equivalent (Gao et al., 2014). Skeletal muscle satellite cells are not 
limited to the myoblast lineage, and have showed osteogenic potential in numerous 
conditions. Following treatment with BMP’s, satellite cells have differentiated in 
osteocytes both in vivo and in vitro when also treated with platelet-rich plasma, and 
have also been observed expressing both myoblastic and osteoblastic markers (Davis 
et al., 2015). Satellite cells are capable of spontaneously differentiating into 
osteoblasts as seen in the pathological condition fibrodysplasia ossificans progressiva, 
where muscle tissue becomes bone due to a mutation in BMP receptors. The 
impressive capability of satellite cells also has great potential for engineering 
treatment where bone marrow or the periosteum is compromised. Myogenic cells with 
MyoD expression contribute to fracture repair but are not found in the developing 
callus if the fracture allowed the periosteum to remain intact. Conversely, when the 
periosteum is damaged myogenic cells can act as a secondary supply of 
osteoprogenitor cells (Shah et al., 2013). This close relationship between muscle and 
bone is further extended through studies that show the density of bone is diminished 
with muscle disuse atrophy, denervation, or immobilization proving the importance of 
the mechanical relationship between bone and muscle (Davis et al., 2015).  
 
Methods of Muscle Injury in Study 
There are multiple models of muscle injury to use for the investigation of 
muscle repair mechanisms. Some of the most common methods are freeze, barium 
chloride, injected toxins (notexin and cardiotoxin), and physical injury (irradiation, 
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crush, and denervation) (Hardy et al., 2016). The repair mechanisms for each model is 
different as demonstrated by the different response of satellite cells and gene 
expression observes during repair for each model of injury. 
The freezing muscle injury model destroys up to 96% of satellite cells in 
addition to the basal lamina and vasculature, and the regeneration process is much 
slower than the other methods, where there is only a 40% satellite cell decrease seen 
for other injury methods. The regeneration process is also much slower than with the 
freezing model compared to other models, but provides the only opportunity for 
researchers to observe infiltration of a muscular dead zone post injury (Hardy et al., 
2016). Muscular dead zones bear similarity to volumetric muscle loss (VML) injuries 
characterized by military personnel. There is a complete loss of elements that 
contribute to muscle regeneration in VML injuries making recovery an unlikely 
possibility, and the remaining fibrosis and chronic loss of function progressively 
worsens over time (Hurtgen et al., 2016). VML injuries are also shown to delay 
fracture healing due to the disruptive effects on immune cell response.  
 Freeze injured muscle is the only method to see a complete return of satellite 
cells after a month long period, other methods see cycling of the stem cell population 
(actively processing through the cell cycle) three months after initial injury. The 
cardiotoxin model of muscle injury induced a dramatic increase of 20% in satellite cell 
number at just one-month post injury compared to injury models with barium chloride, 
notexin, and freeze injury. The number of satellite cells continued to increase 3-fold at 
three months post injury compared to the non-injured muscle. Inflammatory cells 
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remained elevated a month after injury with notexin and freeze injury models, while 
returning to baseline in cardiotoxin and barium chloride models.  
Other considerations for the use of muscle trauma models is that none of the 
injury methods produced damage so significant that satellite cells were unable to 
recover (Hardy et al., 2016). Chemical models of injury use toxins that must be 
injected into the muscle of interest. However, toxins may not be distributed thoroughly 
throughout the muscle and therefore the targeted tissue will not be damaged and 
further analysis will be skewed (Hardy et al., 2016).  
The method of injury is selected to mimic true conditions or mechanisms of 
injury and should be purposely selected by researchers with real life application in 
mind.  In order to further the scope of knowledge surrounding bone fractures and 
healing, we selected blunt trauma injury to isolate the muscle regeneration/repair 
pathway and discover the cellular signaling molecules that serve in duality.  
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SPECIFIC AIMS 
Aim 1: Characterize the process of muscle repair after blunt trauma injury by 
investigating the temporal expression of myogenic and myokine genes. 
Aim 2: Investigate angiogenesis following muscle trauma injury by examining the 
temporal expression of known angiogenic genes. 
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METHODS 
Animals 
All mice used in the studies performed were approved by The Institutional 
Care and Use Committee at Boston University and in compliance with the Animal 
Welfare Act in accordance with the principles of the Guide for the Care and Use of 
Laboratory Animals. The mouse strain Pax7tm1(cre/ER2)Gaka/J (Pax7-Cre) was obtained 
from The Jackson Laboratories and were bred with the reporter strain, B6.Cg-
Gt(ROSA)26sor<tm14(CAG-tdTomato)Hze>/J. These offspring were subsequently 
bred with B6,129S7-Rag1tm1Mom/J mice to generate the Pax7/Ail4/Rag mice which 
were used in this study. Male mice were used for this study and housed in standard 
conditions. A total of two mice were used for each time point of the study with a total 
of seven time points. Male mice were used in this study.  
Procedural Preparations  
 Tamoxifen (10 mg/ml of corn oil) (Sigma-Aldrich) was injected into the 
intraperitoneal space at 10 μL per gram of body weight. Two injections were 
administered within three days followed by a one-month wash out period.  
Muscle Injury 
Mice were initially anesthetized using 4% isoflurane and oxygen, and 2% to 
maintain condition until completion of the procedure. The total procedure ranged from 
3 to 5 minutes and was performed on a warm heated mat which the mice remained on 
until awaking from surgery. Animals received Buprenex (analgesia) and Baytril 
(antibiotic prior to muscle trauma. Blunt trauma injury was introduced via a one-time 
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drop of a weight from a height of 31 mm to the region of the quadriceps femoris 
muscle (Figure 1, Figure 3). Both the right and left limbs received injury.  
 
 
 
 
Figure 1 Muscular Anatomy of Mouse LegThis image illustrates the relative skeletal anatomy of the 
mouse leg. The quadriceps Femoris would drape over the visualized tissue, and was the targeted 
location of impact for the device pictured in Figure 3. 
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Figure 2: Muscle Contusion Device.This image illustrates the muscle contusion device used in our 
injury model. Mice received a single weight drop to each hind limb.  
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Animal Harvest 
Mice were harvested at time points post-operative day (POD) 0, 2, 4, 8, 12, 16, 
and 24. The POD 0 animals did not receive injury and served as our controls. Animals 
were euthanized using carbon dioxide followed by cervical dislocation. Harvest 
weight was recorded. A hind limb was harvested and placed in 4% PFA for 3-4 days at 
4°C. Tissue was then places in 1X PBS and stored at 4°C for future histological 
analysis. The remaining hind limb was used for gene expression analysis. 
Anterolateral femoral quadriceps muscles (including Femoris, vastus medialis) was 
separated from posteromedial (biceps muscles) muscle during harvest and were flash 
frozen in liquid nitrogen (LN2). Samples were stored at -80 °C.  
Histology and Imaging  
To prepare samples for histological staining tissue was first fixed in a 4% (pH 
7.4) paraformaldehyde (PFA) solution for 48-96 hours, decalcified at 4°C in 
Ethylenediamine Tetraacetic Acid (EDTA) for 4-5 days, and agitated in a solution of 
7.5% sucrose/PBS/optimum cutting temperate (OCT) (7.5 ml) compound at 4°C 
overnight. Over the next two nights the agitation process was repeated with 30% 
sucrose/PBS/OCT and 50% sucrose/PBS/OCT respectively. Samples were embedded 
by immersing the sample into a basin filled with tetrafluorethane surrounded by liquid 
nitrogen for about one minute until the sample was completely frozen. Samples were 
stored in -80 ̊C until sectioned. 
 Blocks were sectioned on a Reichert-Jung Cryocut 1800 at 8-10 µm to yield 
12-15 slides per tissue sample. Slides were then mounted on Superfrost Plus slides and 
 23 
air dried at room temperature before storage at -20 °C. Samples used for histology 
were stained with hematoxylin and eosin (H&E) stains for bright field imaging or 
stained with Molecular Probes ProLong © Gold Antifade reagent with DAPI, (4,6-
diamidino-2-phenylindole), a fluorescent stain that binds strongly to adenine–thymine 
rich regions in DNA. Images of tissue sections were acquired using an Olympus BX51 
(Olympus America, Inc., Center Valley, PA) at 10x magnification using CellSens 
Dimensions 4.1.0.0, Olympus America software for photo editing.  
 
RNA Extraction 
 In order to extract RNA from tissue samples, tissue was first removed from the 
freezer and placed on ice. 0.75 ml of Qiazol Reagent and a stainless steel ball were 
added to the cold sample before it was placed into the tissue lyser, Qiagen TissueLyser 
II. The sample was lysed for 2 or 3 intervals, or as long as it took for the sample to 
become liquefied but not thawed. 1 mL Qiazol and 200 μL of 1-Bromo-3-
chloropropane (BCP) were then added up to 2 ml before centrifuging (Eppendorf 
make and model) for 15 minutes at 14000 rpm at 4 °C. The aqueous phase of the 
solution was transferred to a new tube with 70% ethanol and centrifuged for a total of 
40 additional minutes. The extracted pellet was dissolved in RNase-free H2O and 
stored at -80 °C until use.  
Gel Electrophoresis, 1.5% agarose gel run at 110 V for 60-75 minutes, was 
used to determine the quality of extracted RNA. Absorbance spectrometry 
(ThermoScientific Nanodrop 2000 Spectrophotometer) was used to determine the 
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concentration of RNA extracted. The Nanodrop was blanked usimg ultrapure distilled 
water and (2μL) samples were pipetted into the reader. The absorbance was measured 
at settings were set to 260 and 280 nm. 
Quantitative Real Time Polymerase Chain Reaction (qPCR)  
RNA samples were thawed and kept on ice for the duration of this process. 
RNA (2μg) was diluted into 10.4 μl with RNase-free water. Reagents from Taqman 
Reverse Transcription Kit, RNase Inhibitor, and Taqman Reverse Transcriptase (RT) 
were mixed together before adding to samples. 19.6 μL of the Reverse Transcriptase 
Polymerase Chain Reaction (RT-PCR) was added to the 10.4 μL of RNA for a total of 
30 μL. The samples were then loaded into the Eppendorf Thermal Cycler which ran at 
25 °C for 10 minutes, 37 °C for 60 minutes, 95 °C for 5 minutes and finally held at 4 
°C. Samples were then diluted 1:50 and stored at -20 °C.  
Gene primers were purchased from Applied Biosystems and are listed in 
(Table 1). To prepare the samples for the RT-qPCR machine, 10 μL of Universal 
Master Mix (Applied Biosystems® Cat# 4304437) and 1 μL of primer set were added. 
A list of primers used can be found in Table 1.  Each well contained 9 μL of diluted 
cDNA and 11 μl of the primer master mix. Each sample was run in 
duplicate/triplicate, with a control sample of ultrapure distilled water (9 μL) 
primer/master mix (11 μL) included on each plate. Samples were centrifuged for 2 
minutes at 1500 rpm to get rid of bubbles, covered with clear film (Applied 
Biosystems Cat# 4306311) and wrapped in foil before being placed in the ABI 7700 
Sequence Detector from Applied Biosystems. The RT-qPCR machine cycled 40 times 
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through the following cycle: 50 °C for 2 minutes, 95 °C for 15 seconds, and 60 °C for 
1 minute. Threshold cycle (Ct) values were recorded. Data were analyzed using the 
ΔΔCt approach; target genes were normalized to 18s and control (POD 0). Results are 
presented as fold change compared to control.  
Statistical Analysis 
 Statistical analysis of the data was accomplished using Microsoft Excel 2016 
software. Statistical significance was determined with a single-factor ANOVA and a 
Tukey range test to elucidate means that were significantly different from each other. 
Significance value was set to p<0.05.  
 
 
 
 
\ 
 
 
 
 
 
 
 
 
 26 
 
Table 1: Applied Biosystems Primers 
 
 
 
 
 
 
Primers Catalog Number 
#4331182 
18s Mm04277571_s1 
MyoD Mm00521984_m1 
Myf5 Mm00435125_m1 
Myosin 1 MHC (Myh1)  Mm01332489_m1 
MLC2 Myosin Light Chain – 2 (Myl2) Mm00440384_m1 
Interleukin 6 (IL-6) Mm00446190_m1 
Pax7 Mm01354484_m1 
Myostatin (MSTN) Mm01254559_m1 
VegfA Mm00437304_m1 
VegfR2 (Kdr) Mm00440099_m1 
ID-1  Mm00775963_g1 
Prx1 Mm00440932_m1 
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RESULTS 
 The goals of this study are to characterize the temporal progression of 
myogenesis during muscle repair that will be used with future studies of muscle and 
bone injury. And to identify potential crosstalk mechanisms between muscle and bone 
repair during trauma.  
 
Satellite/Stem Cell  
 
 
Figure 3: Pax 7 gene expression following blunt trauma injury. This figure illustrates temporal 
Pax 7 expression in skeletal muscle cells for 24 days. (n=2 at each time point) *denotes 
statistical significance at p<0.05. 
 
 Satellite cells are marked by the expression of Pax 7. Femoral quadriceps 
muscles show an initial decrease in Pax 7 expression at POD 4 (Figrure 4). The 
expression of Pax 7 in the quadriceps reaches a peak, approximately a 4 fold increase 
compared to the control muscle at POD 16. The expression returns to baseline by POD 
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24. The difference in means at POD 4 and POD 16 proved to be statistically 
significant with p<0.05.  While in the biceps muscles the expression of Pax 7 shows a 
non-significant increase from POD 2 to POD 12.   
 
 
Figure 4: Prx1 gene expression following blunt trauma injury. This figure illustrates temporal Prx1 
expression in skeletal muscle cells for 24 days. (n=2 at each time point) 
 The Prx1 expression cell population is known to contribute to fracture repair 
and ectopic bone formation. The expression of Prx1 in the femoral quadriceps muscles 
show a peak expression of approximately 2 fold over the control at POD 16. The 
expression returns to baseline by POD 24. While in the biceps muscles the expression 
of Pax 7 show a 1.5-fold increase compared to the control muscle at POD 12.    
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Myogenic Genes 
 
Figure 5: MyoD gene expression following blunt trauma injury. This figure illustrates Myf5 expression in 
skeletal muscle cells for 24 days following blunt trauma injury. (n=2 at each time point) p<0.05 
 During myogenesis, the expression of MyoD increases indicating cell lineage 
commitment and myogenic programming is marked by increased Myf5 protein. In this 
model of muscle regeneration, MyoD gene expression in the femoral quadriceps and 
biceps muscles were undetectable on POD 2 (Figure 6). In the femoral biceps muscles, 
the expression of MyoD increased to a quarter of the baseline expression at POD 4. 
Between POD 12 and 16 the MyoD expression increased to nearly half of the baseline 
gene expression. And by POD 24 the MyoD gene expression returned to near its POD 
4 expression levels. MyoD detected in the femoral quadriceps muscles at POD 4 was 
shown to be 1.5 times that of control levels before decreasing to half of the expression 
levels of the control at POD 12 through POD 24.  
 In the femoral quadriceps muscles Myf 5 expression was near baseline at POD 
2 and increased to 1.75 times the control expression at POD 4 (Figure 7). The Myf 5 
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expression decreased at POD 12, however, the expression rebounded to approximately 
1.5 times the control expression at POD 24.  The expression of Myf5 in the femoral 
biceps muscles did not show change in expression across time.  
 
 
Figure 6: Myf5 gene expression following blunt trauma injury. This figure illustrates temporal Myf 
5 expression in skeletal muscle cells for 24 days following blunt trauma injury. (n=2 at each time point) 
p<0.05. 
The adult myosin light chain and adult myosin heavy chain are expressed in 
myofibers. These genes were probed in this muscle injury model (Figure 8 and 9). In 
the biceps, Myl2 (myosin light chain 2), expression was at baseline at POD 2, 
however, by POD 4 the gene expression showed approximately a 6-fold increase over 
the control muscle. Between POD 4 and POD 12 the expression levels of Myl2 
decreased to near baseline and continued to decrease through POD 16 and 24. At POD 
24 expression was close to undetectable. Myl2 expression in the quadriceps showed 
very little fluctuation between POD 2 through POD 12, with expression levels 
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remaining near baseline. At POD 16 Myl2 expression increased to 3-fold compared to 
the control and by POD 24 the expression levels were 17-fold compared to control.  
 
 
 
Figure 7: Myl2 gene expression following blunt trauma injury. This figure illustrates Myl2 expression in 
skeletal muscle cells for 24 days following blunt trauma injury. (n=2 at each time point) p<0.05. 
 
Similar levels of myosin heavy chain (Myh1) expression were detected 
between the femoral biceps muscles and the femoral quadriceps muscles at POD 2 
through POD 12. POD 16 there was a divergence of expression levels with Myh1 
levels in the femoral bicep muscles decreasing to less than a fifth of the control values 
at POD 16 and a tenth of the control expression at POD 24. In the quadriceps Myh1 
expression increased from baseline at POD 12 to a 2-fold change compared to the 
control at POD 16. Myh1 expression at POD 24 was undetectable.  
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Figure 8: Myh1 gene expression following blunt trauma injury. This figure illustrates Myh1 expression in 
skeletal muscle cells for 24 days following blunt trauma injury. (n=2 at each time point) p<0.05. 
 
Angiogenesis 
VEGF-A expression in the femoral biceps muscles at POD 2 was 1.25 fold 
above control values, and decreased to half of the baseline expression by POD 4 
(Figure 10). And showed a non-significant peak at POD 12. In the femoral quadriceps 
muscles VEGF-A expression was half of the expression of the control values at POD 2 
and showed a slight decreased at POD 4. The expression of VEGF-A showed a steady 
increase in expression through POD 16 with a 1.5 fold change compared to the control 
muscle. However, at POD 24, VEGF-A levels in the femoral quadriceps muscles 
decreased to around three-quarters of the baseline expression in the muscle.  
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Figure 9: VEGF-A gene expression following blunt trauma injury. This graph illustrates VEGF-A 
gene expression in skeletal muscle for 24 days following blunt trauma injury. (n=2 at each time point) 
p<0.05  
 
 
 
 
 
Figure 10: VEGF-A gene expression following blunt trauma injury. This graph illustrates VEGFR2 
gene expression in skeletal muscle for 24 days following blunt trauma injury. (n=2 at each time point) 
p<0.05 
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 In the femoral biceps muscles the VEGFR-2 expression was a quarter of the 
control expression values at POD 2 (Figure 11). The peak expression of VEGFR-2 
was at POD 12 and was about the same as to the control values.  The expression 
decreased at POD 16 and continued to show low levels of expression through POD 24. 
VEGFR-2 gene expression in the femoral quadriceps muscles remained fairly constant 
from POD 2 through POD 4, remaining at forty-percent of the control baseline. At 
peak expression there was a 1.5-fold change compared to control values at POD 16.  
 
Myokines 
 
Figure 11: Myostatin gene expression following blunt trauma injury. This graph illustrates myostatin gene 
expression in skeletal muscle for 24 days following blunt muscle trauma. (n=2 at each time point) 
 
 Myostatin is a myokine and is a negative regulator of muscle mass. The 
expression of Myostatin in the femoral biceps muscles at POD 2 showed about a 0.4 
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fold change compared to the control and increased through POD 12 when expression 
peaked (Figure 12).  Myostatin expression in the femoral quadriceps muscles showed 
not changed compared to the control at POD 2 but decreased with a 0.4 fold change at 
POD 4. By POD 16, Myostatin expression peaked with a 1.2-fold change.   
Interleukin-6 expression is also known as a myokine. The expression of IL-6 in 
the femoral biceps muscles showed a 0.5 fold change compared to the control muscles 
at POD 2 (Figure 13). The expression increased 1.5 fold at POD 4 which was the peak 
expression. In the quadriceps IL-6 expression showed a 1.5 fold increase compared to 
the control muscle at POD 2. The expression continued to increase at POD 4 but 
decreased to baseline levels at POD 12. Expression increased to nearly 2.5-fold 
control values at POD 16. 
 
Figure 12: IL-6 gene expression following blunt trauma injury. This figure illustrates IL-6 gene expression 
in skeletal muscle cells for 24 days following blunt trauma injury. (n=2 at each time point)  p<0.05 
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BMP Signaling 
 
Figure 13: ID1 gene expression following blunt trauma injury. This figure illustrates ID1 gene expression 
in skeletal muscle cells for 24 days following blunt trauma injury. (n=2 at each time point) p<0.05 
 
 BMP signaling induces the expression of ID1. There was little expression of 
ID1 in the femoral biceps muscles at POD 2 (Figure 15). The gene expression 
increased to about half of the control muscle values at POD 4 and approached baseline 
levels by POD 12. The expression of ID1 peaked at POD 12 followed by a decrease to 
half of control expression values at POD 16. ID1 expression in the femoral quadriceps 
muscles at POD 2 was around one-fifth of control values. By POD 4, ID1 expression 
was 1.5 times the expressive values of the control muscle. Between POD 4 and POD 
12 the expression decreased to half of the control muscle values before increasing to 
baseline by POD 16 and at POD 24 increased approximately 1.5-fold compared to 
control muscle.  
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DISCUSSION 
 We’ve learned from Hardy et al. that damaged skeletal muscle repairs 
at a variable pace depending on the type of injury. Most skeletal muscle studies set a 
repair period of one-month after onset of injury, and some choose to extend the 
observation period up to three months. Here we look at 24 days to suggest a trend in 
the overall healing process of skeletal muscle due to blunt force trauma. Muscle 
impacted by the muscle contusion device exists in the area of the quadriceps, while 
muscle not in the direct path of the device would likely be found in the biceps.  
 
Pax 7 expression  
Pax 7 expression in actively proliferating satellite cells is lowered compared to 
quiescent cells and down regulated in cells committed to terminal differentiation 
(Olguin et al., 2007). We’ve also seen that satellite cells are activated as early as 18 
hours post trauma due to chemical stimulus (Baoge et al., 2012) one would expect a 
lowered Pax 7 expression in these proliferating cells. The quadriceps being in direct 
line of injury show a dip in gene expression compared to the control four days after 
injury.  
Ectopic expression of Pax7 can efficiently repress the MyoD-dependent 
conversion of mesenchymal cells to the muscle lineage. Overexpression of Pax-7 also 
promotes cell cycle exit even in proliferation conditions. Together, these results 
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suggest that Pax-7 may play a crucial role in allowing activated satellite cells to 
reacquire a quiescent, undifferentiated state.  
 
Myogenic gene expression 
 MyoD plays a major role in inducing cells into the myogenic lineage but has 
very little expression in mature skeletal muscle cells. Fig. 6 shows MyoD had 
undetectable values two post injury and spike in expression by day four. This could 
suggest that MyoD aided in the induction of satellite cell proliferation into the 
myogenic lineage. Seeing the spike only in the quadriceps muscle and not the biceps 
muscle may also suggest that because the quadriceps cells dealt with the brunt force of 
the trauma, the damage induced the MyoD only on the lateral side of the skeletal 
muscle.  
 Myf5 functions in myogenesis as a cell cycle regulator, as Myf 5 expression 
regulates when cells will enter or exit the cell cycle. Myf 5 expression should increase 
as a skeletal muscle matures, with its highest expression occurring in adult skeletal 
muscle because adult muscle has exited the cell cycle. Fig. 5 shows a fairly stable 
level of Myf 5 expression in the bicep muscle, which was deep to the muscle 
contusion injury. The expression of Myf 5 after day twelve of injury may suggest that 
there is an increase in the number of maturing skeletal muscle fibers, or an increase in 
Myf 5 signaling to nearby skeletal muscle.  
Myosin light chain kinase and myosin heavy chain are both components of adult 
skeletal muscle. Expression of both contractile proteins should increase as healing 
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continues to occur in days post injury. In Fig. 7 we see that the expression of myosin 
light chain kinase does not increase in the quadriceps muscle until after the twelfth day 
post injury. The spike in seen after day sixteen may suggest that the skeletal muscle 
has left the repair phase of healing and enters the remodeling phase. The repair phase 
is characterized by the regeneration of myofibers and the formation of scar tissue and 
the remodeling phase is defined by the maturation of myoblasts into myofibers and the 
reorganization of the muscle through contractions, which requires light chain kinase.  
Myosin heavy chain kinase shows a similar trend to the activity of myosin light chain 
kinase. After day twelve there is marked increase in the expression of the ATP-
dependent heavy chain myosin which showed an upward trend though from days 
twelve to sixteen.  
Angiogenic gene expression  
Interleukin-1 is a powerful inflammatory cytokine that aid in maturing 
neutrophils for their role in removing necrotic tissue after damage has occurred. Fig. 9 
shows that four days after injury IL-1 levels remained 1.5 fold over their control 
counterparts. This is in accordance with the fact that neutrophil levels can remain 
elevated for up to five fays with skeletal muscle injury (Tidball et al., 2005). Seeing 
the change in expression occur first in the quadriceps and then a smaller increase in 
IL-1 in the biceps on day twelve may suggest that a directional or wave movement of 
the immune response through damaged tissues.  
By examining IL-6 expression we would not expect to see excess production 
of IL-6, as it may indicate improper muscle healing and or functioning. IL-6 levels can 
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also assess the overall health of the muscle days after injury. Fig. 10 shows an initially 
higher IL-6 level in day two POD muscle why may suggest that IL-6 infiltration to the 
site of damage in the quadriceps. On day four we see that the level of IL-6 has equated 
between the bicep and the quadriceps which reiterates the findings of Tidball et al. 
Compared to the IL-6 levels in the biceps, which peak on day four and decline over 
the next twenty days, the spike on day 16 of IL-6 in the quadriceps muscle may be an 
indication secondary injury, or delayed healing. 
VEGF-A is a proangiogenic growth factor that exists in endothelial cell-cell 
junctions. VEGF-A also induces mitosis in endothelial cells. Fig. 11 shows an increase 
in VEGF-A expression in the quadriceps with a peak at POD sixteen, which may 
suggest the surrounding demand for an expanded microvasculature. VEGF-A 
expression also increases when there is stretch tension on capillary walls or 
hyperemia, due to increased blood flow through the vasculature. The drop in 
expression of VEGF-A in the quadriceps after day sixteen may indicate that the 
vascular regeneration process is completed in majority by that time.  
VEGFR-2 is part of a complex that transduces signals related to the turbulence 
of blood flow to polarity molecules that alter gene expression. Fig. 12 shows an 
increase of the expression of VEGFR-2 from POD day 2 until POD day 16, and then a 
drop in the quadriceps expression. Conversely the POD day 2 value of the bicep 
VEGFR-2 may suggest that the bicep muscles experienced an increase in turbulent 
blood flow between the initial injury and POD 2. As the quadriceps regenerated 
skeletal muscle fibers and vasculature, turbulent or increased blood flow in the bicep 
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capillaries may be reflected as the near parallel increase in VEGF-A among both 
muscle groups.  
Myostatin (MSTN) is a muscle derived protein of the TGF-β family, with an 
inhibitory role in muscle growth and fracture repair. MSTN expression is elevated 
with significant musculoskeletal injury, though this remains poorly understood. Fig. 
13 shows peaks in MSTN in the bicep on day twelve and on the quadriceps on day 
sixteen. This may suggest a regulatory mechanism that helps prevent unnecessary 
hypertrophy in skeletal muscle tissue after weeks of regeneration.    
 
Conclusion and Future Directions  
 Overall this study hoped to elucidate some of the highly coordinated processes of 
skeletal muscle repair and regeneration.  There are many complex mechanisms 
involved in the muscle repair and regeneration pathway that are yet to be understood. 
In further studies, researchers should aim to expand their sample size to N ≥ 5 per time 
point in order to better reflect behavioral population. We would also recommend 
smaller dilutions (1:5 or no dilution) of the cDNA used to run the primers in RT-qPCR 
in order to reduce the chance of getting more undetectable values in the RT-qPCR 
results.  
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